IQVIA reports strong Q3 2026 financial results
Revenue grew 8% to $4.4 billion with adjusted EPS up 11%, and the company raised full-year guidance.
See the latest news and media coverage for IQVIA. We track all announcements, press releases, and industry mentions in real time, all in one place.
Life sciences data, technology, analytics, and services provider
iqvia.comLast updated
In short: IQVIA reported strong Q3 2026 results with 8% revenue growth and raised its full-year guidance.
Revenue grew 8% to $4.4 billion with adjusted EPS up 11%, and the company raised full-year guidance.
Revenue reached $4.37 billion while adjusted EPS rose to $3.15. The company increased its full-year outlook for revenue, EBITDA, and earnings per share reflecting strong demand.
The company submitted a current report filing on September 9, 2026, with downloads available in PDF and Excel formats.
The subsidiary will issue senior notes due 2034 with a 6.375% interest rate, expected to close around September 23, 2026, under customary conditions.
While reporting financial results for the third quarter on Tuesday, life sciences services company IQVIA Holdings Inc. ( IQV) raised its adjusted earnings and revenue...
IQVIA Holdings (IQV) reported robust Q2 2026 results, with 8.7% revenue growth and a 19% increase in Research & Development Solutions bookings.
Health-data analytics company IQVIA Solutions Italy has been fined €7 million by the national privacy regulator over a database covering around a million patients in...
The publicly traded company has been buying across the pharma services stack.
Track IQVIA and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to IQVIA and other trending companies.